2013
DOI: 10.1371/journal.pone.0070298
|View full text |Cite
|
Sign up to set email alerts
|

Mutation of GDP-Mannose-4,6-Dehydratase in Colorectal Cancer Metastasis

Abstract: Fucosylation is a crucial oligosaccharide modification in cancer. The known function of fucosylation in cancer is to mediate metastasis through selectin ligand-dependent processes. Previously, we found complete loss of fucosylation in the colon cancer cell line HCT116 due to a mutation in the GDP-fucose synthetic enzyme, GDP-mannose-4,6-dehydratase (GMDS). Loss of fucosylation led to escape of cancer cells from tumor immune surveillance followed by tumor progression and metastasis, suggesting a novel function … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(19 citation statements)
references
References 18 publications
1
18
0
Order By: Relevance
“…Interestingly, mutations in VCAN have been implicated in several ophthalmologic disorders (29). Of interest, known POAG genes also fit in the pathways identified in this study, for example GAS7 and SIX6 play a role during development (27,30), TGFBR3 has been implicated in extracellular matrix regulation (31) and in cancer as well as GMDS (32). Common variants in CDKN2B and its antisense CDKN2B-AS1 have been robustly found associated with POAG.…”
Section: à5supporting
confidence: 54%
“…Interestingly, mutations in VCAN have been implicated in several ophthalmologic disorders (29). Of interest, known POAG genes also fit in the pathways identified in this study, for example GAS7 and SIX6 play a role during development (27,30), TGFBR3 has been implicated in extracellular matrix regulation (31) and in cancer as well as GMDS (32). Common variants in CDKN2B and its antisense CDKN2B-AS1 have been robustly found associated with POAG.…”
Section: à5supporting
confidence: 54%
“…These data were not further developed and need to be evaluated on the light of recent papers dealing with the derangement of fucosylation occurring in cancer. A general loss of the fucosylation potential has been reported in fact in up to 13% of colorectal cancers due to mutations of an enzyme involved in the biosynthesis of GDP-Fuc [86,87], the mandatory donor of fucose in all fucosyltransferase-catalyzed reactions. Such mutation and the consequent loss of fucosylation was very recently reported to enhance inflammation and tumors in the mouse [88].…”
Section: Regulation Of Slea and Slexmentioning
confidence: 99%
“…For example, increase in fucosylated alpha-fetoprotein is seen in sera of patients with hepatocellular carcinoma 21 . By comparison, loss of fucosylation due to mutation of GMDS is reported in colon cancer cell lines and up to 13% of colorectal cancer (CRC) tissues 22, 23 . A search of the Cancer Genome Atlas (TCGA) reveals that homozygous deletions of GMDS are found in 2% of a published CRC database and in 5.5% of a provisional database 24 (www.cbioportal.org).…”
Section: Introductionmentioning
confidence: 99%